Shuch, Brian <br/><br/>
MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors.  [electronic resource] 

 -  BioMed research international  2015 
 - 192406 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2314-6141 
<br/><br/><label>Standard No.: </label>10.1155/2015/192406  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--antagonists & inhibitors<br/>Carcinoma, Renal Cell--enzymology<br/>Female<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Kidney Neoplasms--enzymology<br/>Male<br/>Neoplasm Metastasis<br/>Nephrectomy<br/>Protein Kinase Inhibitors--administration & dosage<br/>Proto-Oncogene Proteins c-met--agonists<br/>Retrospective Studies<br/>Tissue Array Analysis